Provided by Tiger Fintech (Singapore) Pte. Ltd.

CERo Therapeutics Holdings, Inc.

0.9343
+0.02432.67%
Volume:63.58K
Turnover:57.87K
Market Cap:2.83M
PE:-0.03
High:0.9343
Open:0.8855
Low:0.8855
Close:0.9100
Loading ...

Cero Therapeutics Officer YK Bioventures Opportunities GP I, LLC Sold 3,250,000 Shares

SEC Track
·
15 Nov 2024

CERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer Data

TIPRANKS
·
12 Nov 2024

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live
·
12 Nov 2024

Top Midday Gainers

MT Newswires Live
·
12 Nov 2024

Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results

Benzinga
·
11 Nov 2024

Cero Therapeutics presents preclinical data on CER-1236

TIPRANKS
·
11 Nov 2024

BRIEF-Cero Therapeutics Holdings fails to regain compliance with Nasdaq MVLS requirement

Reuters
·
02 Nov 2024

Cero Therapeutics Holdings Inc - Fails to Regain Compliance With Nasdaq Mvls Requirement

THOMSON REUTERS
·
02 Nov 2024

Cero Therapeutics files to sell 713.56M shares of common stock for holders

TIPRANKS
·
22 Oct 2024

BRIEF-Cero Therapeutics, Inc. Provides Corporate Update

Reuters
·
21 Oct 2024

Cero Therapeutics Holdings: to Adjust Our Previous Guidance About Potential Entry Into Clinic From 2024 to Early 2025

THOMSON REUTERS
·
21 Oct 2024

Cero Therapeutics, Inc. Provides Corporate Update

THOMSON REUTERS
·
21 Oct 2024

CERo Therapeutics Names Andrew Kucharchuk CFO, Kristen Pierce Chief Development Officer

MT Newswires Live
·
02 Oct 2024

Cero Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer

THOMSON REUTERS
·
02 Oct 2024

CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer

GlobeNewswire
·
02 Oct 2024

CERo Therapeutics Names Interim CEO, Secures Financing; Shares Rise

MT Newswires Live
·
25 Sep 2024